Sickle Cell Disease Vaso-occlusive Crisis: Clinical Trials

1 recruiting. 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	1	Recruiting 1

Follow Sickle Cell Disease Vaso-occlusive Crisis: new trials by email Literature Review of Sickle Cell Disease Vaso-occlusive Crisis trials Research Report on Sickle Cell Disease Vaso-occlusive Crisis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis CSL889, Placebo - Sickle Cell Disease Vaso-occlusive Crisis	Phase 2	Recruiting	CSL Behring	70	2025-07-10	2026-10-08

Narrower conditions

Acute Chest Syndrome (1)  ·  Acute Kidney Injury (1)  ·  Anemia, Sickle Cell (1)  ·  Vaso-Occlusive Crises (1)

Broader conditions

Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Anemia, Hemolytic, Congenital (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hemoglobinopathies (1)  ·  Kidney Diseases (1)  ·  Lung Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Renal Insufficiency (1)  ·  Respiration Disorders (1)

Interventions

Hemopexin (1)

Sponsors

CSL Behring (1)

Countries

Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)